A-107: Improving Early Detection of Mild Cognitive Impairment Using Cognitive, Sensory, and Blood-Based Markers
Objective: Mild cognitive impairment (MCI) is often considered a transitional stage between normal aging and Alzheimer’s disease. Individuals with MCI exhibit cognitive decline that is greater than expected for age but insufficient for a dementia diagnosis. This study evaluated the accuracy of cognitive, olfactory, a...